Two bills introduced in Congress recently stake out rival positions on a key issue related to health care reform. Which approach ultimately prevails will help
Jul 31, 2020104.8K Shares1.9M Views
Two bills introduced in Congress recently stake out rival positions on a key issue related to health care reform.Which approach ultimately prevails will help determine whether the pharmaceutical industry maintains the support that Pfizer CEO [Jeffrey Kindler voiced Wednesday ](http://money.cnn.com/news/newsfeeds/articles/djf500/200903181902DOWJONESDJONLINE001003_FORTUNE5.htm">Kindler told CNN)for President Obama’s plan’s to overhaul the nation’s health care system.
Reps. Anna Eshoo (D-Calif.), Jay Inslee (D-Wash.) and Joe Barton (R-Texas) introduced a bill Tuesday that would give manufacturers of new drugs up to 14 years of market exclusivity
Maybe, says Kindler, who heads the world’s largest pharmaceutical manufacturer. He told CNN,